Related Experiment Video
Updated: Mar 15, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Laryngeal Leishmaniasis with Extra-pulmonary Tuberculosis
Swati Tayal1, Saurav Khatiwada1, Priyanka Sehrawat1
1Department of Internal Medicine.
This case report details isolated laryngeal leishmaniasis and extra-pulmonary tuberculosis (EPTB) co-infection, a rare occurrence. It outlines diagnostic and treatment strategies for this unusual presentation in a resource-limited tropical setting.
Area of Science:
- Infectious Diseases
- Parasitology
- Otolaryngology
Background:
- Leishmaniasis presents in various forms, including visceral, cutaneous, mucocutaneous, mucosal, and post-kala-azar dermal.
- Mucosal leishmaniasis typically affects oral and nasal passages, with laryngeal involvement being rare.
- Co-infection with tuberculosis (TB) is uncommon, particularly in isolated laryngeal leishmaniasis.
Purpose of the Study:
- To report a rare case of isolated laryngeal leishmaniasis.
- To describe its association with extra-pulmonary tuberculosis (EPTB).
- To outline diagnostic and treatment approaches in a resource-limited tropical environment.
Main Methods:
- Case report of a patient presenting with symptoms suggestive of laryngeal involvement.
- Diagnostic workup including clinical examination, imaging, and parasitological confirmation.
- Review of management strategies for co-existing laryngeal leishmaniasis and EPTB.
Main Results:
- The patient presented with isolated laryngeal leishmaniasis.
- The case was complicated by co-infection with extra-pulmonary tuberculosis (EPTB).
- Successful diagnosis and treatment were achieved despite resource limitations.
Conclusions:
- Isolated laryngeal leishmaniasis is a rare clinical presentation.
- Concomitant EPTB requires careful diagnostic consideration and tailored treatment.
- Effective management is achievable even in resource-limited settings with a systematic approach.
More Related Videos
05:55In Vivo Imaging of Leishmania infantum-infected Hamsters by Gingival Inoculation of Axenic Amastigotes Expressing Luciferase
Published on: April 4, 2025
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Other Pulmonary Disorders